AzTrials
AzTrials

Catarct ScreeningAINCT05204095

Intelligent Cataract Screening With Portable Slit-lamp

An observational study of Catarct Screening and Artificial Intelligence, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Based on the portable slit-lamp connected to the smartphone, the artificial intelligence machine learning algorithm is used to establish a cataract screening model by prospectively collecting the anterior segment photographic data, and a portable slit lamp intelligent screening referral model based on the smartphone… Read more about this study

Who is it for?
Ages Up to 100 yearsHealthy volunteers can take part
Conditions the study is for
Catarct Screening, Artificial Intelligence
What is being tested?
Portable slit-lamp photography
Type of treatment
Medical device
How many people
3,000 participants
Where
1 siteChina
Study dates
10 Feb 2022to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The prospective population aged 0 to 100 with or without senile cataracts and received ocular examination.

Who may be able to join

  • 0 to 100 years old

Who cannot join

  • (1) History of eye disease except for age-related cataracts (2) History of eye trauma or eye surgery (3) Unable to cooperate with ophthalmology and general examination (4) Individuals with incomplete information (5) Unwilling to participate in this study

Trial locations and contacts

1 site in 1 country.

Haotian Lin, M.D., Ph.D. contact

+86-020-87330274

gddlht@aliyun.com

China1 site
  • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

    Guangzhou, Guangdong, 510060

    Haotain Lin, M.D., Ph.D., +86-020-87330274, gddlht@aliyun.com

Other trials in China

About this study

Based on the portable slit-lamp connected to the smartphone, the artificial intelligence machine learning algorithm is used to establish a cataract screening model by prospectively collecting the anterior segment photographic data, and a portable slit lamp intelligent screening referral model based on the smartphone connection is also established.

Being tested
Portable slit-lamp photography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Portable slit-lamp photographyDevice

    The enrolled patients will undergo portable slit-lamp photography with and without mydriasis and receive traditional slit-lamp photography for comparison.

Study groups in NCT05204095
Study groupRoleWhat they receive
Referral groupThe patients with severe cataracts in this group need a referral to a higher-level hospital for further treatment.
Receives: Device: Portable slit-lamp photography
Observation groupThe patients with mild cataracts or transparent lenses in this group do not need a referral to a higher-level hospital for further treatment and keep regular examinations.
Receives: Device: Portable slit-lamp photography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The accuracy of referral

    The accuracy of referral of AI model will be calculated with the decisions based on the portable slit-lamp images with reference to the ground truth.

    Measured: Baseline

Secondary outcomes (1)
  1. The accuracy of cataract diagnosis

    The accuracy of cataract diagnosis of AI model will be calculated with the decisions based on the portable slit-lamp images with reference to the ground truth.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2022
  2. Study start10 Feb 2022 (estimated)
  3. Primary completion30 Jun 2023 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05204095
Sponsor's protocol ID
SLCS-2022
Acronym
AI
Status last verified
Jan 2022
First submitted
10 Jan 2022
Last updated
24 Jan 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Catarct Screening and Artificial Intelligence, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Haotian Lin, M.D., Ph.D. (+86-020-87330274, gddlht@aliyun.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The accuracy of referral (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in